Location of Repository

A possible modulatory role for prostacyclin (PGI2) INIgGa-induced release of slow-reacting substance of anaphylaxis in rats.

By J F Burka and L G Garland

Abstract

Antigen challenge in vivo of rat peritoneal cells (enriched with monocytes and polymorphonuclear leucocytes) passively sensitized 2 h previously with homologous antibody of the IgGa class released large amounts of slow-reacting substance of anaphylaxis (SRS-A, 1739 +/- 59 u/ml) into the peritoneal fluid. This reaction was strongly inhibited by prostacyclin (PGI2, ED50 = 0.5 microgram/kg i.p.) and by isoprenaline (ED50 = 0.2 microgram/kg i.p.) but prostaglandins E1, E2 and 6-oxo-prostaglandin F1alpha were only weak inhibitors. Indomethacin (10 mg/kg, orally) augmented by 30% the release of SRS-A, whereas thromboxane B2 (50 microgram/kg i.p.) had no effect. Lowering the antigen (ovalbumin) dosage from 400 microgram/ml to 10 microgram/ml reduced the control release of SRS-A by 70% and increased the inhibitory effect of prostaglandins I2, E1 and isoprenaline. Augmentation of release by indomethacin remained unchanged. These preliminary data suggested that endogenous prostacyclin may modulate the anaphylactic release of SRS-A from rat peritoneal cells

Topics: Research Article
OAI identifier: oai:pubmedcentral.nih.gov:1668065
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.